UNSPSC 85815204: Introduction of analgesics, hypnotics, sedatives into respiratory tract, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of analgesics, hypnotics, sedatives into respiratory tract, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0F8NZ

UNSPSC 85815204 (Introduction of analgesics, hypnotics, sedatives into respiratory tract, via natural or artificial opening endoscopic) is a Commodity code that shows minimal relevant recent state and local procurement activity. The recent opportunities tagged under this code do not reflect pharmaceutical administration via respiratory route; instead, they span virtual urgent care, medical services, PACE operations, cancer registry support, retinal screening devices, EMS staffing, employee health clinics, occupational health services, and behavioral health platforms—activities entirely outside the scope of anesthetic or sedative drug delivery through endoscopic respiratory procedures. The code appears to be a misclassification artifact in one or more procurement systems, as none of the seventeen listed opportunities involve pharmaceutical induction of sedation or analgesia through respiratory tract access.

Issuing bodies in the sample include state health authorities (Nevada Health Authority, Texas HHSC, Colorado Department of Human Services), county health systems and sheriffs' offices (Santa Clara, Brevard, Forsyth, DeKalb, Seminole), city governments (Phoenix, Atlanta, Ocala), school districts (Parkway), transit authorities, and special-purpose entities (Sourcewell cooperative, Events DC, Inland Empire Health Plan). Activity concentrates in California, Texas, Georgia, Colorado, Florida, Nevada, and Washington state, with scattered single opportunities across Kansas, Oregon, New York, Illinois, Arizona, and the District of Columbia. The most recent opportunities cluster around occupational health services, behavioral health and substance use treatment (particularly opioid-use-disorder programs funded by settlement monies), emergency medical services staffing, cancer screening and registry support, and employee wellness administration—none of which align with the code's stated scope of respiratory-tract drug delivery. Given the complete mismatch between code definition and actual procurement activity, this code warrants investigation as a tagging error rather than pursuit as an active procurement category.